Skip to main content

Table 9 Anchor-based assessment of meaningful change for NVSA© scores with sPGA

From: Development and psychometric validation of the Nausea/Vomiting Symptom Assessment patient-reported outcome (PRO) instrument for adults with secondary hyperparathyroidism

 

Number of Days of Vomiting or Nausea

Number of Episodes of Vomiting

Mean Severity of Nausea

sPGA Score Used

n, mean Δ between weeks, SE Δ

n, mean Δ between weeks, SE Δ

n, mean Δ between weeks, SE Δ

 

Minimally Worsen

Minimally Worsen

Minimally Worsen

Week 2-Week 1

(n = 7)

0.68 (0.50)

 

(n = 7)

0.31 (0.16)

Week 3-Week 2

(n = 7)

0.58 (0.86)

 

(n = 7)

−0.39 (0.78)

Week 4-Week 3

   

Week 5-Week 4

   

Week 6-Week 5

(n = 8)

0.59 (0.57)

(n = 6)

1.42 (0.92)

(n = 8)

0.23 (0.10)

Week 7-Week 6

(n = 6)

0.17 (0.70)

 

(n = 6)

0.48 (0.34)

Week 8-Week 7

   

Mean

0.50

1.42

0.16

Median

0.58

1.42

0.27

 

Minimally Improve

Minimally Improve

Minimally Improve

Week 2-Week 1

(n = 7)

−1.80 (0.92)

 

(n = 7)

−1.02 (0.47)

Week 3-Week 2

(n = 7)

0.11 (0.84)

(n = 6)

−1.03 (0.35)

(n = 7)

−0.46 (0.24)

Week 4-Week 3

(n = 6)

− 1.07 (0.52)

 

(n = 6)

− 0.15 (0.16)

Week 5-Week 4

   

Week 6-Week 5

   

Week 7-Week 6

(n = 7)

− 0.68 (0.68)

(n = 7)

−1.64 (1.02)

(n = 7)

− 0.22 (0.21)

Week 8-Week 7

   

Mean

−0.86

−1.33

−0.46

Median

−0.87

−1.33

−0.34

  1. Empty rows = sample size < n = 6 for minimally improve or minimally worsen and analyses not conducted
  2. n = sample size; Δ = change score; SE = standard error